menu search

ZURA / Why Shares of Zura Bio Climbed Tuesday

Why Shares of Zura Bio Climbed Tuesday
Zura Bio's lead therapy is ZB-106. The company plans to start two phase 2 trials for the therapy. Read More
Posted: Jun 20 2023, 17:33
Author Name: The Motley Fool
Views: 1116100

ZURA News  

Why Shares of Zura Bio Climbed Tuesday

By The Motley Fool
June 20, 2023

Why Shares of Zura Bio Climbed Tuesday

Zura Bio's lead therapy is ZB-106. The company plans to start two phase 2 trials for the therapy. more_horizontal

ZURA Stock Alert: Zura Bio SPAC Merger Rally Ends

By InvestorPlace
March 23, 2023

ZURA Stock Alert: Zura Bio SPAC Merger Rally Ends

Zura Bio (NASDAQ: ZURA ) stock is on the move Thursday following the clinical-stage biotechnology company's recent public debut. Zura Bio went public more_horizontal


Search within

Pages Search Results: